BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22230571)

  • 21. Structure and modeling of knottins, a promising molecular scaffold for drug discovery.
    Gracy J; Chiche L
    Curr Pharm Des; 2011 Dec; 17(38):4337-50. PubMed ID: 22204432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrogating and predicting tolerated sequence diversity in protein folds: application to E. elaterium trypsin inhibitor-II cystine-knot miniprotein.
    Lahti JL; Silverman AP; Cochran JR
    PLoS Comput Biol; 2009 Sep; 5(9):e1000499. PubMed ID: 19730675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystine-knot peptides engineered with specificities for α(IIb)β(3) or α(IIb)β(3) and α(v)β(3) integrins are potent inhibitors of platelet aggregation.
    Silverman AP; Kariolis MS; Cochran JR
    J Mol Recognit; 2011; 24(1):127-35. PubMed ID: 21194123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid isolation of high-affinity protein binding peptides using bacterial display.
    Bessette PH; Rice JJ; Daugherty PS
    Protein Eng Des Sel; 2004 Oct; 17(10):731-9. PubMed ID: 15531628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applications of novel affinity cassette methods: use of peptide fusion handles for the purification of recombinant proteins.
    Hearn MT; Acosta D
    J Mol Recognit; 2001; 14(6):323-69. PubMed ID: 11757069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinatorial optimization of cystine-knot peptides towards high-affinity inhibitors of human matriptase-1.
    Glotzbach B; Reinwarth M; Weber N; Fabritz S; Tomaszowski M; Fittler H; Christmann A; Avrutina O; Kolmar H
    PLoS One; 2013; 8(10):e76956. PubMed ID: 24146945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering of a femtomolar affinity binding protein to human serum albumin.
    Jonsson A; Dogan J; Herne N; Abrahmsén L; Nygren PA
    Protein Eng Des Sel; 2008 Aug; 21(8):515-27. PubMed ID: 18499681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold.
    Nygren PA
    FEBS J; 2008 Jun; 275(11):2668-76. PubMed ID: 18435759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
    Skerra A
    FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticalins small engineered binding proteins based on the lipocalin scaffold.
    Gebauer M; Skerra A
    Methods Enzymol; 2012; 503():157-88. PubMed ID: 22230569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma.
    Moore SJ; Hayden Gephart MG; Bergen JM; Su YS; Rayburn H; Scott MP; Cochran JR
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14598-603. PubMed ID: 23950221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design of phage-displayed cystine-stabilized mini-protein libraries for proteinaceous binder engineering.
    Chang HJ; Yang AS
    Methods Mol Biol; 2014; 1088():1-17. PubMed ID: 24146393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supramolecular Surface Immobilization of Knottin Derivatives for Dynamic Display of High Affinity Binders.
    Sankaran S; de Ruiter M; Cornelissen JJ; Jonkheijm P
    Bioconjug Chem; 2015 Sep; 26(9):1972-80. PubMed ID: 26270829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fibronectin type III domain as a scaffold for novel binding proteins.
    Koide A; Bailey CW; Huang X; Koide S
    J Mol Biol; 1998 Dec; 284(4):1141-51. PubMed ID: 9837732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient Enzymatic Ligation of Inhibitor Cystine Knot Spider Venom Peptides: Using Sortase A To Form Double-Knottins That Probe Voltage-Gated Sodium Channel Na
    Agwa AJ; Blomster LV; Craik DJ; King GF; Schroeder CI
    Bioconjug Chem; 2018 Oct; 29(10):3309-3319. PubMed ID: 30148615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative non-antibody scaffolds for molecular recognition.
    Skerra A
    Curr Opin Biotechnol; 2007 Aug; 18(4):295-304. PubMed ID: 17643280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage display for engineering and analyzing protein interaction interfaces.
    Sidhu SS; Koide S
    Curr Opin Struct Biol; 2007 Aug; 17(4):481-7. PubMed ID: 17870470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbodies.
    Schmoldt HU; Daneschdar M; Kolmar H; Blind M
    Methods Mol Biol; 2009; 535():361-72. PubMed ID: 19377985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered cystine-knot miniproteins for diagnostic applications.
    Kolmar H
    Expert Rev Mol Diagn; 2010 Apr; 10(3):361-8. PubMed ID: 20370592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein selection using yeast surface display.
    Gera N; Hussain M; Rao BM
    Methods; 2013 Mar; 60(1):15-26. PubMed ID: 22465794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.